China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. The company employs 6,095 full-time employees The company went IPO on 2010-09-28. The firm's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The firm distributes its products within domestic market and to overseas markets.
00867.HK stock price ended at $15.08 on 星期一, after dropping 0.33%
On the latest trading day Feb 16, 2026, the stock price of 00867.HK fell by 0.33%, dropping from $15.10 to $15.08. During the session, the stock saw a volatility of 1.34%, with prices oscillating between a daily low of $14.91 and a high of $15.11. On the latest trading day, the trading volume for 00867.HK decreased by 1.6M shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 116.0K shares were traded, with a market value of approximately $36.7B.